Inhalation therapy device
AssigneePARI Pharma GmbH
InventorsCarolin Stoeckl, Tobias Hoffmann, Benjamin Heine, Markus Reinhart, Thomas Denis
Life of this patent
Estimating the term…
Loading patent…
AssigneePARI Pharma GmbH
InventorsCarolin Stoeckl, Tobias Hoffmann, Benjamin Heine, Markus Reinhart, Thomas Denis
Estimating the term…
The disclosure concerns an inhalation therapy device inter alia comprising: a sensor (47) configured to detect a flow parameter of the flow in a flow path (7), a controller (18) configured to conclude based on the output of the sensor (47) at least on an inhalation phase and/or an exhalation phase of a user and to, during a single treatment time, repeatedly operate an actuator (6) during a period of the inhalation phase and not operate the actuator (6) during a period of the exhalation phase, wherein an aerosol output rate of the inhalation therapy device at the first opening (8) during the single treatment time is, when using a test solution of albuterol 0.1% (M/V) concentration in 0.9% sodium chloride as the liquid, at least 0.48 g/min at a Median Mass Diameter of aerosol droplets between 4.5 μm and 5.0 μm, or at least 0.42 g/min at a Median Mass Diameter of aerosol droplets between 4.0 μm and 4.5 μm, or at least 0.29 g/min at a Median Mass Diameter of aerosol droplets between 3.5 μm and 4.0 μm, or at least 0.20 g/min at a Median Mass Diameter of aerosol droplets between 3.0 μm and 3.5 pμm, or at least 0.13 g/min at a Median Mass Diameter of aerosol droplets between 2.5 μm and 3.0 μm.
Inhalation therapy device comprising:
Dependencies are inferred from the claim text.